Clinical trial Recruiting at 1 site Observational

Collecting data on thyroid, parathyroid, and adrenal diseases

Official title: Comprehensive Data Collection and Follow-Up for Patients With Thyroid, Parathyroid and Adrenal Disease

Run by M.D. Anderson Cancer Center · NCT03050762 · Data updated 2026-11-12

This study is collecting health information from people with thyroid, parathyroid, and adrenal diseases to see how these conditions affect them over time.

Quick facts

Study typeObservational
SexAll
Enrollment15000 (estimated)
SponsorM.D. Anderson Cancer Center
Academic / other
Locations1 site (Houston, Texas)
StatusRecruiting
StartedOctober 5, 2011
Main results expectedOctober 2026
Study endsOctober 2027
Registry record updatedSeptember 17, 2019
Trial IDNCT03050762 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients diagnosed or suspected of having endocrine diseases who are being seen at MD Anderson.

Probably not a fit

Patients without a diagnosis or suspicion of endocrine disease may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to gather comprehensive data on patients with thyroid, parathyroid, and adrenal diseases. Participants will have their medical records reviewed and information entered into a research database at MD Anderson. The study will track the current or suspected illnesses, surgeries, and recoveries of participants over a period of up to 15 years, with follow-up phone calls starting 2-3 years after diagnosis or treatment. This long-term data collection will help researchers better understand these endocrine diseases.

Why it matters

Potential benefit: If successful, this study could enhance understanding of endocrine diseases, potentially leading to improved patient outcomes and treatment strategies.

How similar studies have gone: Other studies focusing on data collection for chronic diseases have shown success in improving patient care and outcomes.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. All patients that are being seen at MD Anderson with diagnosed or suspected endocrine disease. Patients will be selected from patients undergoing evaluation and/or treatment in the Endocrine Center, either by selection from a participating Endocrine physician or by screening from study personnel for patients scheduled to be seen in the Endocrine Clinic.
2. In addition, we intend to contact family members of patients who are enrolled on the study, and found to be deceased at follow-up, to request permission to obtain cause of death, to determine whether cause of death may be related to endocrine disease.

Exclusion Criteria:

N/A

Where it's running

  • University of Texas MD Anderson Cancer Center
    Houston, Texas, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.